Commit and Sexually active - a phase IV clinical study of FDA data
Summary:
We study 4,930 people who take Commit (nicotine polacrilex) or have Sexually active. No report of Sexually active is found in people who take Commit.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Commit?
Commit has active ingredients of nicotine polacrilex. eHealthMe is studying from 4,842 Commit users. Check the latest studies of Commit.
What is Sexually Active?
Sexually active is found to be associated with 2 drugs and 12 conditions by eHealthMe. Check the latest studies of Sexually active.
No report is found.
Do you take Commit and have Sexually active?
- Check whether Sexually active is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Commit:
- Commit (4,842 reports)
Sexually active treatments and more:
- Sexually active (88 reports)
How severe was Sexually active and when was it recovered:
Expand to all the drugs that have ingredients of nicotine polacrilex:
Browse all side effects of Commit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Sexually active:
Browse all the conditions that are associated with Sexually active:
How the study uses the data?
The study uses data from the FDA. It is based on nicotine polacrilex (the active ingredients of Commit) and Commit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pepcid and Hyperkalaemia for Women aged 40-49 - a second ago
- Pepcid and Blood Potassium Increased for Women aged 40-49 - 2 seconds ago
- Pepcid and Elevated Potassium for Women aged 40-49 - 2 seconds ago
- Pepcid and Potassium - High for Women aged 40-49 - 2 seconds ago
- Pepcid and High Potassium for Women aged 40-49 - 3 seconds ago
- Pepcid and Hyperkalemia for Women aged 40-49 - 3 seconds ago
- Sirolimus and Lisinopril drug interactions for men aged 40-49 - 10 seconds ago
- Cellcept and Hair Loss for Men aged 60+ - 12 seconds ago
- Cellcept and Hair Thinning for Men aged 60+ - 12 seconds ago
- Cellcept and Loss Of Hair for Men aged 60+ - 13 seconds ago